Peripheral CD300a+CD8+ T Lymphocytes with a Distinct Cytotoxic Molecular Signature Increase in Pregnant Women with Chronic Chorioamnionitis

American Journal of Reproductive Immunology

Volumn 67, Issue 3, 2012, Pages 184-197

  Xu, Yi ^a,b   Tarquini, Federica ^a,b   Romero, Roberto ^a,b   Kim, Chong Jai ^a,b,c   Tarca, Adi L ^a,b,d   Bhatti, Gaurav ^a,b   Lee, Joonho ^a,b   Sundell, I Birgitta ^a,b   Mittal, Pooja ^a,b,c   Kusanovic, Juan Pedro ^a,b,c   Hassan, Sonia S ^a,b,c   Kim, Jung Sun ^a,b,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Wayne State University   (United States)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Maternal antifetal rejection; Placenta; Prematurity; Preterm birth; Transcriptome

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; CARDIOTROPHIN 1; CD150 ANTIGEN; CD244 ANTIGEN; CD300A ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; COMPLEMENT FACTOR H; CYTOKINE RECEPTOR; DECAY ACCELERATING FACTOR; DROSOPHILA PROTEIN; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERLEUKIN 15; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOSTATIN M; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE C ALPHA; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CHORIOAMNIONITIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CHORIOAMNIONITIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PREGNANCY; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; YOUNG ADULT;

EID: 84856365086     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01088.x     Document Type: Article

References (57)

1. Koch CA, Platt JL: T cell recognition and immunity in the fetus and mother. Cell Immunol 2007; 248:12-17.
2. Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, Chavez SL, Romero R, Mor G: Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol 2007; 57:55-66.
3. Leiser R, Kaufmann P: Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994; 102:122-134.
4. Redline RW: The structural basis of maternal-fetal immune interactions in the human placenta. Curr Top Microbiol Immunol 1997; 222:25-44.
5. Hunt JS, Petroff MG, McIntire RH, Ober C: HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19:681-693.
6. Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601-610.
7. Fraccaroli L, Alfieri J, Larocca L, Calafat M, Mor G, Leiros CP, Ramhorst R: A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation. Hum Reprod 2009; 24:166-175.
8. Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I, Leiros CP, Mor G: Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol 2011 doi: [Epub ahead of print].
9. Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E: Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 76:147-151.
10. Kumru S, Boztosun A, Godekmerdan A: Pregnancy-associated changes in peripheral blood lymphocyte subpopulations and serum cytokine concentrations in healthy women. J Reprod Med 2005; 50:246-250.
11. Luppi P, Haluszczak C, Trucco M, Deloia JA: Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002; 47:72-81.
12. Mahmoud F, Abul H, Omu A, Al-Rayes S, Haines D, Whaley K: Pregnancy-associated changes in peripheral blood lymphocyte subpopulations in normal Kuwaiti women. Gynecol Obstet Invest 2001; 52:232-236.
13. Tallon DF, Corcoran DJ, O'Dwyer EM, Greally JF: Circulating lymphocyte subpopulations in pregnancy: a longitudinal study. J Immunol 1984; 132:1784-1787.
14. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, Amino N: Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997; 37:368-377.
15. Daish A, Starling GC, McKenzie JL, Nimmo JC, Jackson DG, Hart DN: Expression of the CMRF-35 antigen, a new member of the immunoglobulin gene superfamily, is differentially regulated on leucocytes. Immunology 1993; 79:55-63.
16. Silva R, Moir S, Kardava L, Debell K, Simhadri VR, Ferrando-Martinez S, Leal M, Pena J, Coligan JE, Borrego F: CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection. Blood 2011; 117:5870-5880.
17. Clark GJ, Rao M, Ju X, Hart DN: Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression. J Leukoc Biol 2007; 82:1126-1135.
18. Narayanan S, Silva R, Peruzzi G, Alvarez Y, Simhadri VR, Debell K, Coligan JE, Borrego F: Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesodermin. PLoS One 2010; 5:e10636.
19. Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee DC, Draghici S, Gotsch F, Kusanovic JP, Hassan SS, Kim JS: Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 2009; 182:3919-3927.
20. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-193.
21. Smyth G: Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, R Gentleman, V Carey, W Huber, R Irizarry, S Dudoit (eds). New York, Springer, 2005, pp 397-420.
22. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57:289-300.
23. Falcon S, Gentleman R: Using GOstats to test gene lists for GO term association. Bioinformatics 2007; 23:257-258.
24. Khatri P, Draghici S, Ostermeier GC, Krawetz SA: Profiling gene expression using onto-express. Genomics 2002; 79:266-270.
25. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R: A systems biology approach for pathway level analysis. Genome Res 2007; 17:1537-1545.
26. Tarca AL, Romero R, Draghici S: Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol 2006; 195:373-388.
27. Redline RW, Ariel I, Baergen RN, Desa DJ, Kraus FT, Roberts DJ, Sander CM: Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7:443-452.
28. Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY, Prashner HR, Waters BL: Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7:237-249.
29. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C: Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6:435-448.
30. Redline RW, Heller D, Keating S, Kingdom J: Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 2005; 26(Suppl A):S114-S117.
31. Khong TY, Bendon RW, Qureshi F, Redline RW, Gould S, Stallmach T, Lipsett J, Staples A: Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol 2000; 31:292-295.
32. Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, Gotsch F, Yoon BH, Chi JG, Kim JS: The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 2010; 23:1000-1011.
33. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
34. Alvarez Y, Tang X, Coligan JE, Borrego F: The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol Immunol 2008; 45:253-258.
35. Bachelet I, Munitz A, Berent-Maoz B, Mankuta D, Levi-Schaffer F: Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J Immunol 2008; 180:6064-6069.
36. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L, Moretta A: Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 1999; 29:3148-3159.
37. Ju X, Zenke M, Hart DN, Clark GJ: CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 2008; 112:1184-1194.
38. Lankry D, Simic H, Klieger Y, Levi-Schaffer F, Jonjic S, Mandelboim O: Expression and function of CD300 in NK cells. J Immunol 2010; 185:2877-2886.
39. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F: The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006; 107:1996-2003.
40. Wang M, Windgassen D, Papoutsakis ET: Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation. BMC Genomics 2008; 9:225.
41. Shashkin P, Simpson D, Mishin V, Chesnutt B, Ley K: Expression of CXCL16 in human T cells. Arterioscler Thromb Vasc Biol 2003; 23:148-149.
42. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T: Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168:6173-6180.
43. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y: A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999; 29:3596-3602.
44. Rose TM, Bruce AG: Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci U S A 1991; 88:8641-8645.
45. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, McIntyre TM: Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 1997; 100:158-168.
46. Broxmeyer HE, Bruns HA, Zhang S, Cooper S, Hangoc G, McKenzie AN, Dent AL, Schindler U, Naeger LK, Hoey T, Kaplan MH: Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity 2002; 16:815-825.
47. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, Takano S: Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999; 162:1278-1286.
48. Jin LP, Fan DX, Zhang T, Guo PF, Li DJ: The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage. Am J Reprod Immunol 2011; 66:270-278.
49. Kheshtchin N, Gharagozloo M, Andalib A, Ghahiri A, Maracy MR, Rezaei A: The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am J Reprod Immunol 2010; 64:104-112.
50. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
51. Toldi G, Rigo J Jr, Stenczer B, Vasarhelyi B, Molvarec A: Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 2011; 66:223-229.
52. Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou GX, Luo LH, Luan HB: Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol 2011; 65:503-511.
53. de Groot CJ, van der Mast BJ, Visser W, De Kuiper P, Weimar W, Van Besouw NM: Preeclampsia is associated with increased cytotoxic T-cell capacity to paternal antigens. Am J Obstet Gynecol 2010; 203:496. e1-6.
54. Yang KM, Ntrivalas E, Cho HJ, Kim NY, Beaman K, Gilman-Sachs A, Kwak-Kim J: Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood T cell activation. Am J Reprod Immunol 2010; 63:370-378.
55. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B, Oleszczuk J: Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007; 58:39-45.
56. Gersell DJ, Phillips NJ, Beckerman K: Chronic chorioamnionitis: a clinicopathologic study of 17 cases. Int J Gynecol Pathol 1991; 10:217-229.
57. Jacques SM, Qureshi F: Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998; 29:1457-1461.